Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway

Zhou,Yang; Lian,Hongyu; Liu,Kexin; Wang,Deli; Xiu,Xuelian; Sun,Zhang

doi:10.3892/ijmm.2020.4595

Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway

Authors:
- Yang Zhou
- Hongyu Lian
- Kexin Liu
- Deli Wang
- Xuelian Xiu
- Zhang Sun
View Affiliations

Affiliations: Department of Stomatology, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China, Second Department of Orthopedics Surgery, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China, Department of Stomatology, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157000, P.R. China
Published online on: May 6, 2020 https://doi.org/10.3892/ijmm.2020.4595
Pages: 239-251
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone graft defects may lead to dysfunction of bone regeneration and metabolic disorders of bone mesenchymal stem cells (BMSCs). Puerarin has demonstrated pharmacological activities in the treatment of human metabolic diseases. The purpose of the present study was to investigate the role of puerarin and to explore its possible protective mechanism of action in rats with bone grafts. A bone graft rat model was established using bone grafting surgery and the rats received puerarin or PBS. Reverse transcription‑quantitative PCR, western blot, TUNEL, immunofluorescence and immunohistochemistry assays were used to analyze the beneficial effects of puerarin on bone repair. The results demonstrated that puerarin effectively ameliorated pathological graft bone defects, decreased bone loss and apoptosis of BMSCs, promoted BMSC proliferation and differentiation, and increased bone mass and the parameters of bone formation in rats with bone grafts. Puerarin decreased the levels of pro‑inflammatory cytokines [tumor necrosis factor (TNF)‑α, interleukin (IL)‑1β, IL‑17A, IL‑6 and transforming growth factor (TGF)‑β1] and increased the levels of anti‑inflammatory cytokines (IL‑2 and IL‑10) in the serum compared with the PBS group. Puerarin treatment was associated with lower serum alanine transaminase, glutamic oxaloacetic transaminase, γ‑glutamyl transferase, alkaline phosphatase, direct bilirubin and total bilirubin levels compared with those in the PBS group in experimental rats. The expression of microRNA‑155‑3p (miR‑155‑3p) was upregulated, whereas that of p53, TNF‑α and signal transducer and activator of transcription (STAT)1 was downregulated in BMSC cultures of puerarin‑treated rats. In vitro assay demonstrated that knockdown of miR‑155‑3p increased p53, TNF‑α and STAT1 expression in BMSCs, and blocked puerarin‑regulated p53/TNF‑α/STAT1 signaling. Most importantly, miR‑155‑3p knockdown inhibited puerarin‑regulated apoptosis, proliferation and differentiation of BMSCs. Moreover, the results demonstrated that puerarin regulated vascular endothelial growth factor expression via the miR‑155‑3p signaling pathway. In conclusion, the results of the present study demonstrated that the upregulation of miR‑155‑3p induced by puerarin promoted BMSC differentiation and bone formation and increased bone mass in rats with bone grafts, thereby supporting the potential application of puerarin in the prevention of bone graft defects.

View Figures

View References

1	Cha JK, Sanz M and Jung UW: Human autopsy study of peri-implant dehiscence defects with guided bone regeneration: A case report. Int J Periodontics Restorative Dent. 39:517–524. 2019. View Article : Google Scholar
2	Basler T, Naenni N, Schneider D, Hämmerle CHF, Jung RE and Thoma DS: Randomized controlled clinical study assessing two membranes for guided bone regeneration of peri-implant bone graft defects: 3-year results. Clin Oral Implants Res. 29:499–507. 2018. View Article : Google Scholar : PubMed/NCBI
3	Thoma DS, Jung UW, Park JY, Bienz SP, Hüsler J and Jung RE: Bone augmentation at peri-implant dehiscence defects comparing a synthetic polyethylene glycol hydrogel matrix vs. standard guided bone regeneration techniques. Clin Oral Implants Res. 28:e76–e83. 2017. View Article : Google Scholar
4	Martelli A and Santos AR Jr: Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering. Organogenesis. 10:303–311. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ma R, Tang S, Tan H, Qian J, Lin W, Wang Y, Liu C, Wei J and Tang T: Preparation, characterization, in vitro bioactivity, and cellular responses to a polyetheretherketone bioactive composite containing nanocalcium silicate for bone repair. ACS Appl Mater Interfaces. 6:12214–12225. 2014. View Article : Google Scholar : PubMed/NCBI
6	Swales C and Sabokbar A: Cellular and molecular mechanisms of bone damage and repair in inflammatory arthritis. Drug Discov Today. 19:1178–1185. 2014. View Article : Google Scholar : PubMed/NCBI
7	Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z and Goodman SB: Inflammation, fracture and bone repair. Bone. 86:119–130. 2016. View Article : Google Scholar : PubMed/NCBI
8	Wilcox FH and Taylor BA: Genetics of the Akp-2 locus for alkaline phosphatase of liver, kidney, bone, and placenta in the mouse. Linkage with the Ahd-1 locus on chromosome 4. J Hered. 72:387–390. 1981. View Article : Google Scholar : PubMed/NCBI
9	Horta R, Costa J, Valença-Filipe R and Amarante JM: ALT chimeric flap associated to a dura mater biomatrix substitute for severe desfigurative mandible osteoradionecrosis and deficient bone consolidation after a free fibula flap. Br J Oral Maxillofac Surg. 52:670–672. 2014. View Article : Google Scholar : PubMed/NCBI
10	Mohamad Asri SF, Mohd Ramli ES, Soelaiman IN, Mat Noh MA, Abdul Rashid AH and Suhaimi F: Piper sarmentosum effects on 11b-hydroxysteroid dehydrogenase type 1 enzyme in serum and bone in rat model of glucocorticoid-induced osteoporosis. ALT chimeric flap associated to a dura mater biomatrix substitute for severe desfigurative mandible osteoradionecrosis and deficient bone consolidation after a free fibula flap. Molecules. 21:E15232016. View Article : Google Scholar
11	Wang B, Wu S, Ma Z, Wang T and Yang C: BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model. Cell Death Dis. 9:10242018. View Article : Google Scholar : PubMed/NCBI
12	Lin L, Lin H, Bai S, Zheng L and Zhang X: Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int. 115:80–84. 2018. View Article : Google Scholar : PubMed/NCBI
13	Masaoka T, Yoshii T, Yuasa M, Yamada T, Taniyama T, Torigoe I, Shinomiya K, Okawa A, Morita S and Sotome S: Bone defect regeneration by a combination of a β-tricalcium phosphate scaffold and bone marrow stromal cells in a non-human primate model. Open Biomed Eng J. 10:2–11. 2016. View Article : Google Scholar :
14	Li R, Xu L, Liang T, Li Y, Zhang S and Duan X: Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. Food Chem Toxicol. 52:69–75. 2013. View Article : Google Scholar
15	Wang C, Wang W, Jin X, Shen J, Hu W and Jiang T: Puerarin attenuates inflammation and oxidation in mice with collagen antibody-induced arthritis via TLR4/NF-kB signaling. Mol Med Rep. 14:1365–1370. 2016. View Article : Google Scholar : PubMed/NCBI
16	Yin MS, Zhang YC, Xu SH, Liu JJ, Sun XH, Liang C, Wang Y, Li J, Wang FW, Wang QL and Mu YL: Puerarin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of inflammation. J Asian Nat Prod Res. 21:476–493. 2019. View Article : Google Scholar
17	Qin H, Zhang Y, Wang R, Du X, Li L and Du H: Puerarin suppresses Na⁺-K⁺-ATPase-mediated systemic inflammation and CD36 expression, and alleviates cardiac lipotoxicity in vitro and in vivo. J Cardiovasc Pharmacol. 68:465–472. 2016. View Article : Google Scholar : PubMed/NCBI
18	Jiang M, Yun Q, Niu G, Gao Y, Shi F and Yu S: Puerarin prevents inflammation and apoptosis in the neurocytes of a murine Parkinson's disease model. Genet Mol Res. 15:2016. View Article : Google Scholar
19	Wong R and Rabie B: Effect of puerarin on bone formation. Osteoarthritis Cartilage. 15:894–899. 2007. View Article : Google Scholar : PubMed/NCBI
20	Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J and Li B: p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol. 172:115–125. 2006. View Article : Google Scholar
21	Hirasawa H, Tanaka S, Sakai A, Tsutsui M, Shimokawa H, Miyata H, Moriwaki S, Niida S, Ito M and Nakamura T: ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J Bone Miner Res. 22:1020–1030. 2007. View Article : Google Scholar : PubMed/NCBI
22	Hochgreb-Hägele T, Koo DE and Bronner ME: Znf385C mediates a novel p53-dependent transcriptional switch to control timing of facial bone formation. Dev Biol. 400:23–32. 2015. View Article : Google Scholar : PubMed/NCBI
23	Peng M, Wang Y, Qiang L, Xu Y, Li C, Li T, Zhou X, Xiao M and Wang J: Interleukin-35 inhibits TNF-α-induced osteoclastogenesis and promotes apoptosis via shifting the activation from TNF receptor-associated death domain (TRADD)-TRAF2 to TRADD-Fas-associated death domain by JAK1/STAT1. Front Immunol. 9:14172018. View Article : Google Scholar
24	Zhang Y, Zeng X, Zhang L and Zheng X: Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med. 73:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
25	Sheu SY, Tsai CC, Sun JS, Chen MH, Liu MH and Sun MG: Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice. Chin Med J (Engl). 125:3646–3653. 2012.
26	Elton TS, Selemon H, Elton SM and Parinandi NL: Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 532:1–12. 2013. View Article : Google Scholar
27	Min B, Song JS, Kim SO, Kim KM, Park WS and Lee JH: Osteoconduction capacity of human deciduous and permanent teeth ash in a rat calvarial bone defect model. Cell Tissue Bank. 16:361–369. 2015. View Article : Google Scholar
28	Valable AS, Narcy A, Duclos MJ, Pomar C, Page G, Nasir Z, Magnin M and Létourneau-Montminy MP: Effects of dietary calcium and phosphorus deficiency and subsequent recovery on broiler chicken growth performance and bone characteristics. Animal. 12:1555–1563. 2018. View Article : Google Scholar
29	Ñíguez Sevilla B, Rabadan-Ros R, Alcaraz-Baños M, Martínez Díaz F, Mate Sánchez de Val JE, López-Gónzalez I, Calvo-Guirado JL, De Aza PN and Meseguer-Olmo L: Nurse's A-phase-silicocarnotite ceramic-bone tissue interaction in a rabbit tibia defect model. J Clin Med. 8:E17142019. View Article : Google Scholar : PubMed/NCBI
30	Li FQ, Zhou HY, Yang HL, Xiang T, Mei Y, Hu HZ and Wang TH: Isolation and purification of BMScs of GFP transgenic mouse using the method of adhering to cuture plastic in different time. Nurse's A-phase-silicocarnotite ceramic-bone tissue interaction in a rabbit tibia defect model. Sichuan Da Xue Xue Bao Yi Xue Ban. 37:301–304. 2006.In Chinese. PubMed/NCBI
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
32	Arumugam P, Ramamurthy P, Santhiya ST and Ramesh A: Antioxidant activity measured in different solvent fractions obtained from Mentha spicata Linn.: An analysis by ABTS*+ decolorization assay. Asia Pac J Clin Nutr. 15:119–124. 2006.
33	Akar Z, Küçük M and Doğan H: A new colorimetric DPPH(*) scavenging activity method with no need for a spectrophotometer applied on synthetic and natural antioxidants and medicinal herbs. J Enzyme Inhib Med Chem. 32:640–647. 2017. View Article : Google Scholar : PubMed/NCBI
34	Wang X, Sun H, Liao H, Wang C, Jiang C, Zhang Y and Cao Z: MicroRNA-155-3p mediates TNF-α-inhibited cementoblast differentiation. J Dent Res. 96:1430–1437. 2017. View Article : Google Scholar : PubMed/NCBI
35	Kleinheinz J, Stratmann U, Joos U and Wiesmann HP: VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg. 63:1310–1316. 2005. View Article : Google Scholar : PubMed/NCBI
36	Meijndert L, Raghoebar GM, Schupbach P, Meijer HJ and Vissink A: Bone quality at the implant site after reconstruction of a local defect of the maxillary anterior ridge with chin bone or deproteinised cancellous bovine bone. Int J Oral Maxillofac Surg. 34:877–884. 2005. View Article : Google Scholar : PubMed/NCBI
37	Liu H, Li W, Ge X, Jia S and Li B: Coadministration of puerarin (low dose) and zinc attenuates bone loss and suppresses bone marrow adiposity in ovariectomized rats. Life Sci. 166:20–26. 2016. View Article : Google Scholar : PubMed/NCBI
38	Wang L, Zhang H, Rodriguez S, Cao L, Parish J, Mumaw C, Zollman A, Kamoka MM, Mu J, Chen DZ, et al: Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-kB-dependent manner. Cell Stem Cell. 15:51–65. 2014. View Article : Google Scholar : PubMed/NCBI
39	Liu H, Peng H, Wu Y, Zhang C, Cai Y, Xu G, Li Q, Chen X, Ji J, Zhang Y and OuYang HW: The promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds by effects on integrin-BMP/Smad signaling pathway in BMSCs. Biomaterials. 34:4404–4417. 2013. View Article : Google Scholar : PubMed/NCBI
40	Watanabe J, Yamada M, Niibe K, Zhang M, Kondo T, Ishibashi M and Egusa H: Preconditioning of bone marrow-derived mesenchymal stem cells with N-acetyl-L-cysteine enhances bone regeneration via reinforced resistance to oxidative stress. Biomaterials. 185:25–38. 2018. View Article : Google Scholar : PubMed/NCBI
41	Wang L, Zhang HY, Gao B, Shi J, Huang Q, Han YH, Hu YQ, Lu WG, Zhao ZJ, Liu BH, et al: Tetramethylpyrazine protects against glucocorticoid-induced apoptosis by promoting autophagy in mesenchymal stem cells and improves bone mass in glucocorticoid-induced osteoporosis rats. Stem Cells Dev. 26:419–430. 2017. View Article : Google Scholar
42	Gong X, Yu W, Zhao H, Su J and Sheng Q: Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro BMSCs osteogenic activity. Sci Rep. 7:361292017. View Article : Google Scholar : PubMed/NCBI
43	Liu Z, Li T, Deng S, Fu S, Zhou X and He Y: Radiation induces apoptosis and osteogenic impairment through miR-22-mediated intracellular oxidative stress in bone marrow mesenchymal stem cells. Stem Cells Int. 2018:58454022018. View Article : Google Scholar : PubMed/NCBI
44	He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, et al: p53 loss increases the osteogenic differentiation of bone marrow stromal cells. Stem Cells. 33:1304–1319. 2015. View Article : Google Scholar :
45	Yu YQ, Qu L, Qiu LH, Guo JJ, Ma N and Zhu L: Mechanism of TNF-α in bone defect of chronic apical periodontitis. Shanghai Kou Qiang Yi Xue. 25:414–419. 2016.In Chinese. PubMed/NCBI
46	Li J, He X, Wei W and Zhou X: MicroRNA-194 promotes osteoblast differentiation via downregulating STAT1. Biochem Biophys Res Commun. 460:482–488. 2015. View Article : Google Scholar : PubMed/NCBI
47	Wong RW and Rabie AB: Effect of quercetin on preosteoblasts and bone defects. Open Orthop J. 2:27–32. 2008. View Article : Google Scholar : PubMed/NCBI
48	Zhang MY, Qiang H, Yang HQ, Dang XQ and Wang KZ: In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. Chin J Integr Med. 18:276–282. 2012. View Article : Google Scholar : PubMed/NCBI